Radiotherapy for Cancer: Present and Future

doi:10.1016/j.addr.2017.01.004

Editorial

. 2017 Jan 15:109:1-2.

doi: 10.1016/j.addr.2017.01.004.

Radiotherapy for Cancer: Present and Future

Christine Allen¹, Sohyoung Her², David A Jaffray³

Affiliations

¹ Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada M5S 3M2; STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
² Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada M5S 3M2.
³ Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Department of Radiation Physics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Techna Institute, University Health Network, Toronto, Ontario, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.

PMID: 28189183
DOI: 10.1016/j.addr.2017.01.004

Editorial

Radiotherapy for Cancer: Present and Future

Christine Allen et al. Adv Drug Deliv Rev. 2017.

. 2017 Jan 15:109:1-2.

doi: 10.1016/j.addr.2017.01.004.

Authors

Christine Allen¹, Sohyoung Her², David A Jaffray³

Affiliations

¹ Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada M5S 3M2; STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
² Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada M5S 3M2.
³ Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Department of Radiation Physics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Techna Institute, University Health Network, Toronto, Ontario, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.

PMID: 28189183
DOI: 10.1016/j.addr.2017.01.004

No abstract available

PubMed Disclaimer

Cited by

The Landscape of Pediatric Radiation Oncology in Nigeria.
Joseph A, Akinsete AM, Lasebikan NN, Adeneye S, Awofeso OM, Oladipo AT, Ajose AO, Ojo O, Merrell K, Ngwa W, Puthoff DS, Onitilo AA. Joseph A, et al. JCO Glob Oncol. 2024 Jan;10:e2300219. doi: 10.1200/GO.23.00219. JCO Glob Oncol. 2024. PMID: 38207247 Free PMC article. Review.
Ionizing Radiation Induces Disc Annulus Fibrosus Senescence and Matrix Catabolism via MMP-Mediated Pathways.
Zhong J, Chen J, Oyekan AA, Epperly MW, Greenberger JS, Lee JY, Sowa GA, Vo NV. Zhong J, et al. Int J Mol Sci. 2022 Apr 5;23(7):4014. doi: 10.3390/ijms23074014. Int J Mol Sci. 2022. PMID: 35409374 Free PMC article.
Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy.
Kumar GS, Moustafa M, Sahoo AK, Malý P, Bharadwaj S. Kumar GS, et al. Life (Basel). 2022 Apr 29;12(5):659. doi: 10.3390/life12050659. Life (Basel). 2022. PMID: 35629327 Free PMC article.
A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
Xiang X, Kang J, Jiang J, Zhang Y, Zhang Y, Li L, Peng X. Xiang X, et al. Front Immunol. 2023 Jun 28;14:1198391. doi: 10.3389/fimmu.2023.1198391. eCollection 2023. Front Immunol. 2023. PMID: 37449209 Free PMC article.
Effects of ultra-high dose rate radiotherapy with different fractions and dose rate on acute and chronic lung injury in mice.
Gao F, Lin B, Yang Y, Xiao D, Zhou Z, Zhang Y, Feng G, Li J, Wu D, Du X, Shi Q. Gao F, et al. Heliyon. 2024 Nov 14;10(22):e40298. doi: 10.1016/j.heliyon.2024.e40298. eCollection 2024 Nov 30. Heliyon. 2024. PMID: 39641017 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Radiotherapy for Cancer: Present and Future

Affiliations

Radiotherapy for Cancer: Present and Future

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical